Aptus Pharma Limited Approves Authorized Share Capital Increase and 3:2 Bonus Equity Share Issue

Aptus Pharma Limited announced significant corporate restructuring decisions following its Board of Directors meeting held on March 24, 2026. The pharmaceutical company's board approved a substantial expansion of its authorized share capital and recommended a bonus equity share issue, both subject to shareholder approval through postal ballot.

Authorized Share Capital Enhancement

The board approved a proposal to significantly increase the company's authorized share capital structure. The enhancement represents a strategic expansion of the company's equity framework to support future growth initiatives.

Parameter: Current Structure Proposed Structure Authorized Capital: ₹7,15,00,000 ₹25,00,00,000 Number of Shares: 71,50,000 shares 2,50,00,000 shares Face Value: ₹10 per share ₹10 per share

Bonus Equity Share Recommendation

The board considered and recommended issuing bonus equity shares to existing shareholders in a favorable ratio. This recommendation demonstrates the company's commitment to rewarding its shareholder base through equity participation.

Bonus Issue Details: Specifications Bonus Ratio: 3:2 Entitlement: 3 bonus shares for every 2 existing shares Eligibility: Fully paid-up equity shareholders Approval Required: Shareholder consent through postal ballot

Postal Ballot Process Framework

The board approved comprehensive arrangements for conducting the postal ballot process to seek shareholder approval for both proposals. The company has established a structured approach to ensure transparent and efficient voting procedures.

Key Approvals Include:

Draft Postal Ballot Notice with explanatory statement

Appointment of scrutinizer for fair and transparent conduct

Determination of cut-off date and e-voting period

Authorization of company officials for necessary formalities

E-voting Infrastructure

Central Depository Systems Limited (CDSL) has been appointed as the agency for providing remote e-voting facility for the postal ballot process. This appointment ensures professional handling of the electronic voting infrastructure required for shareholder participation.

The board meeting commenced at 5:00 PM and concluded at 7:15 PM on March 24, 2026, at the company's registered office. Managing Director Tejash Hathi (DIN: 03151221) signed the official communication to BSE Limited, confirming the board's decisions and requesting the exchange to take the information on record.

Aptus Pharma Limited has officially scheduled a board meeting for March 24, 2026, to deliberate on significant corporate actions including the issuance of bonus equity shares and an increase in authorized share capital.

Board Meeting Details

The company has issued a formal notice to BSE Limited under Regulation 29 of SEBI Listing Regulations, confirming that the board meeting will be held at their registered office in Rajkot, Gujarat. The meeting agenda includes two key proposals that require board consideration and subsequent shareholder approval.

Meeting Details: Information Date: March 24, 2026 Venue: Rajkot, Gujarat Security Code: 544529 Script Symbol: APPL

Key Agenda Items

The board will consider two significant corporate actions during the meeting. First, the proposal to increase the company's authorized share capital, which will require member approval if recommended by the board. Second, the consideration and recommendation of bonus equity shares, also subject to shareholder approval.

Proposals: Status Authorized Share Capital Increase: Subject to member approval Bonus Equity Shares: Subject to member approval

Trading Window Closure

In compliance with SEBI insider trading regulations, the company has announced a trading window closure for all designated persons and their immediate relatives. The trading restriction will be effective from March 18, 2026, through March 26, 2026, covering the period around the board meeting deliberations.

Corporate Action Significance

Bonus shares represent additional equity shares distributed to existing shareholders without requiring additional payment, typically undertaken to reward shareholders and improve market liquidity. The proposed increase in authorized share capital would provide the company with greater flexibility for future capital-raising activities and corporate restructuring initiatives.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.